Imidazopiperazine inhibitors of transcription activating proteins

The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic disea...

Full description

Saved in:
Bibliographic Details
Main Authors Mandal, Pijus Kumar, Cross, Jason Bryant, Soth, Michael J, Jones, Philip, Carroll, Christopher L, McAfoos, Timothy Joseph, Le, Kang
Format Patent
LanguageEnglish
Published 13.07.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases.
Bibliography:Application Number: US201916370404